Survival of treatment with biological therapies on patients diagnosed with juvenile idiopathic arthritis

被引：0
|
作者：
Abreu Trigueros, P. [1 ]
Rubio Garcia, J. [1 ]
Ruiz Bonilla, G. [1 ]
Laino Pineiro, M. [1 ]
Granados Bautista, I. [1 ]
Gamir Gamir, M. [1 ]
机构：
[1] Univ Hosp Ram, Pediat Rheumatol Unit, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [41] DRUG SURVIVAL AND REASONS FOR DISCONTINUATION OF THE FIRST COURSE OF BIOLOGICAL THERAPY IN 301 JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
    Romano, M.
    Pontikaki, I.
    Gattinara, M.
    Ardoino, I.
    Donati, C.
    Boracchi, P.
    Meroni, P. L.
    Gerloni, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 266 - 266
  • [42] DRUG SURVIVAL OF BIOLOGICAL THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: 10 YEARS EXPERIENCE IN A SINGLE CENTER
    Arsenyeva, S. V.
    Nikishina, I. P.
    Kaleda, M. I.
    Shapovalenko, A. N.
    Rodionovskaya, S. R.
    Fedorov, E. S.
    Alekseev, D. L.
    Medyntzeva, L. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 620 - 621
  • [43] Macrophage activation syndrome during treatment with biological therapy in patients with systemic juvenile idiopathic arthritis
    Alina Lucica Boteanu
    Maria Angeles Blazquez Cañamero
    Valentina Maldonado Romero
    Maria Luz Gámir Gámir
    Pediatric Rheumatology, 12 (Suppl 1)
  • [44] Biological therapies promising in juvenile rheumatoid arthritis
    不详
    Drugs & Therapy Perspectives, 2005, 21 (2) : 8 - 11
  • [45] Inception Cohort of newly diagnosed Patients with juvenile idiopathic Arthritis (ICON) - an Update
    Sengler, C.
    Niewerth, M.
    Liedmann, I.
    Klotsche, J.
    Ganser, G.
    Hospach, A.
    Foell, D.
    Minden, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 90 - 91
  • [46] Persistence and adherence to biologic therapies in juvenile idiopathic arthritis
    Nieto-Gonzalez, Juan Carlos
    Trives-Folguera, Laura
    Melgarejo-Ortuno, Alejandra
    Ais, Aranzazu
    Serrano-Benavente, Belen
    Sanjurjo, Maria
    Alvaro-Gracia, Jose Maria
    Saez, Indalecio Monteagudo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] The safety profile of biologic therapies for juvenile idiopathic arthritis
    Philip J. Hashkes
    Yosef Uziel
    Ronald M. Laxer
    Nature Reviews Rheumatology, 2010, 6 : 561 - 571
  • [48] Persistence and adherence to biologic therapies in juvenile idiopathic arthritis
    Juan Carlos Nieto-González
    Laura Trives-Folguera
    Alejandra Melgarejo-Ortuño
    Aranzazu Ais
    Belén Serrano-Benavente
    María Sanjurjo
    José María Álvaro-Gracia
    Indalecio Monteagudo Sáez
    Scientific Reports, 11
  • [49] The safety profile of biologic therapies for juvenile idiopathic arthritis
    Hashkes, Philip J.
    Uziel, Yosef
    Laxer, Ronald M.
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (10) : 561 - 571
  • [50] Biologic therapies in Juvenile Idiopathic Arthritis: Why and for whom?
    McCann, L. J.
    Woo, P.
    ACTA REUMATOLOGICA PORTUGUESA, 2007, 32 (01): : 17 - +
12345